Tavapadon Bioavailability Study
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What is the purpose of this trial?
This study will assess the relative bioavailability of two different Oral formulations of tavapadon in healthy adult participants.
Research Team
ABBVIE INC.
Principal Investigator
AbbVie
Eligibility Criteria
This trial is for healthy adults who are either permanently sterile or postmenopausal women under 55 with no menses for a year and an FSH level ≥ 30 IU/L. Participants must be in good health as determined by medical exams, have a BMI between 18.0 to ≤ 32.0 kg/m2, and cannot be pregnant or breastfeeding.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive different oral formulations of Tavapadon in multiple sequences and periods
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Tavapadon
Find a Clinic Near You
Who Is Running the Clinical Trial?
AbbVie
Lead Sponsor
Dr. Roopal Thakkar
AbbVie
Chief Medical Officer since 2023
MD from Wayne State University School of Medicine
Robert A. Michael
AbbVie
Chief Executive Officer
Bachelor's degree in Finance from the University of Illinois